AD Pharmaceuticals Inc.

Overview

AD Pharmaceuticals Inc. is a leading pharmaceutical company based in the USA, focused on developing innovative therapies for various medical needs. The company is committed to advancing healthcare solutions through intensive research and development.

Therapeutic areas

API / Drug Master Files

AD Pharmaceuticals Inc. holds 9 active (22 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• APAP MICROCAPSActive2019-06-20
• APT-5076 EXTENDED-RELEASE CAPSULESActive2019-01-23
• APT-5041 EXTENDED-RELEASE CAPSULESActive2018-03-27
• MICROCAPS® IBUPROFENActive2015-10-19
• AR17 -APT5037 IR ORALLY DISINTEGRATING TABLETSActive2015-06-16
• EUR 1030 MICROCAPS®Active2008-10-07
• EUR-1048 ORALLY DISINTEGRATING TABLETSActive2006-10-28
• IBUPROFEN GELATIN/CAPActive1993-03-26
• MICROCAPS® POTASSIUM CHLORIDEActive1985-12-12
• APT-5074 DELAYED-RELEASE TABLETSInactive2018-09-11
• APC-8000 ORAL DISINTEGRATING TABLETSInactive2018-09-07
• APT-5035 EXTENDED-RELEASE CAPSULESInactive2018-07-20
• APT-5032 EXTENDED RELEASE CAPSULESInactive2016-09-22
• AR18 - APT5033 EXTENDED RELEASE ORALLY DISINTEGRATING TABLETSInactive2016-08-23
• LOPERAMIDE MICROCAPS®Inactive2016-04-28

Showing 15 of 22 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to AD Pharmaceuticals Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.